未登录

A

Aliccia Bollig-Fischer

Barbara Ann Karmanos Cancer Institute

H指数:28

被引数:2,384

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Hyperglycemia and O-GlcNAc transferase activity drive a cancer stem cell pathway in triple-negative breast cancer

CANCER CELL INTERNATIONAL

IF6

2023-05-256

OAAI

Role of novel cancer gene SLITRK3 to activate NTRK3 in squamous cell lung cancer

新癌基因SLITRK3激活NTRK3在肺鳞癌中的作用

MOLECULAR BIOMEDICINE

IF10.1

2021-08-306

OA

Role of TET1 and 5hmC in an Obesity-Linked Pathway Driving Cancer Stem Cells in Triple-Negative Breast Cancer

MOLECULAR CANCER RESEARCH

IF4.7

2020-12-0225

OAAI

Expression of alternative mRNA splicing variant MBD2_v2 promotes triple-negative breast cancer tumor initiation and is associated with body mass index

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

IF3.4

2020-06-010

PRE

Detecting qualitative changes in biological systems

检测生物系统中的质变

SCIENTIFIC REPORTS

IF3.9

2020-05-181

OAAI

Profiling the Mutational Landscape in Known Driver Genes and Novel Genes in African American Non-Small Cell Lung Cancer Patients

CLINICAL CANCER RESEARCH

IF10.2

2019-07-1516

OAAI

SRSF2-dependent MBD2v2 expression is induced by obesity and promotes tumor-initiating triple negative breast cancer stem cells

CANCER RESEARCH

IF16.6

2019-07-010

OA

Obesity-induced MBD2_v2 expression promotes tumor-initiating triple-negative breast cancer stem cells

MOLECULAR ONCOLOGY

IF4.5

2019-03-0124

OAAI

Integrating 5hmC and gene expression data infers regulatory mechanisms linked to alternative mRNA splicing in breast cancer

CANCER RESEARCH

IF16.6

2018-07-010

PRE

Exogenous IL-6 induces mRNA splice variant MBD2_v2 to promote stemness in TP53 wild-type, African American PCa cells

MOLECULAR ONCOLOGY

IF4.5

2018-05-2418

OAAI

Role of epigenetic reader and alternative mRNA splicing variant MBD2 variant 2 in triple-negative breast cancer

CANCER RESEARCH

IF16.6

2017-07-010

PRE

Treating triple negative breast cancer cells with erlotinib plus a select antioxidant overcomes drug resistance by targeting cancer cell heterogeneity

SCIENTIFIC REPORTS

IF3.9

2017-03-1050

OAAI

The Role of Pro-Inflammatory Cytokines in Prostate Cancer in African American Men

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

IF3.4

2017-02-050

PRE

How the future of clinical cancer diagnostics can contribute to overcoming race-associated cancer disparities

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

IF3.6

2016-11-111

OAAI

Molecular profiling in African American NSCLC patients to identify novel potential driver mutations

CANCER RESEARCH

IF16.6

2016-07-151

PRE

DEVELOPMENT OF PROSTATE CANCER GENE SIGNATURES AND GENE SCORES OF AGGRESSIVENESS FOR AFRICAN AMERICANS AND EUROPEANS AMERICANS

JOURNAL OF UROLOGY

IF6.8

2016-04-010

OAAI

ELEVATED EXPRESSION OF 15-LIPOXYGENASE-2 (ALOX15B) IS ASSOCIATED WITH NONAGGRESSIVE PROSTATE CANCER AND CONFERS A SURVIVAL BENEFITS

JOURNAL OF UROLOGY

IF6.8

2016-04-011

OA

Targeting the Nuclear Export Protein XPO1/CRM1 Reverses Epithelial to Mesenchymal Transition

SCIENTIFIC REPORTS

IF3.9

2015-11-0534

OAAI

Oncogene signatures identify novel therapeutic targets and combinatorial strategies in breast cancer

CANCER RESEARCH

IF16.6

2015-08-010

PRE

Functional role of miR-10b in tamoxifen resistance of ER-positive breast cancer cells through down-regulation of HDAC4

IF3.4

2015-07-2483

OAAI